Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125463931 | 12546393 | 1 | I | 20160629 | 20160711 | 20160711 | EXP | US-TEVA-675199USA | TEVA | EILERS B, ALBERS E, LAW Y, MIKE MCMULLAN D, SHAW D, KEMNA M. POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME AFTER PEDIATRIC HEART TRANSPLANTATION: INCREASED RISK FOR CHILDREN WITH PREEXISTING GLENN/FONTAN PHYSIOLOGY.PEDIATRIC TRANSPLANTATION. 2016; 20(4):552-558 | 19.00 | YR | F | Y | 0.00000 | 20160711 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125463931 | 12546393 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | U | 78101 | ||||||||||
125463931 | 12546393 | 2 | SS | PHENYTOIN. | PHENYTOIN | 1 | Unknown | U | 0 |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125463931 | 12546393 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125463931 | 12546393 | Posterior reversible encephalopathy syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |